LIGAND PHARMACEUTICALS INCORPORATED Financing Receivable, before Allowance for Credit Loss, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Financing Receivable, before Allowance for Credit Loss, Current of $0 as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableGrossCurrent · last filed 2019-02-28
- 2018-12-31: Financing Receivable, before Allowance for Credit Loss, Current $0.00.
- 2018-03-31: Financing Receivable, before Allowance for Credit Loss, Current $3.88M.
- 2017-12-31: Financing Receivable, before Allowance for Credit Loss, Current $3.88M.
- 2017-09-30: Financing Receivable, before Allowance for Credit Loss, Current $3.01M.
| Period end | Financing Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2018-03-31 | $3.88M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $3.88M 10-K · filed 2019-02-28 |
| 2017-09-30 | $3.01M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.21M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 |
| 2016-12-31 | $3.21M 10-K · filed 2018-03-01 |
| 2016-09-30 | $3.21M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $3.21M 10-Q · filed 2016-11-14 |
| 2016-03-31 | $4.77M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $4.78M 10-K · filed 2017-02-28 |
| 2015-09-30 | $5.55M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $5.55M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-09 |